2026 Global: Hernia Mesh Devices Market-Competitive Review (2032) report
Description
The 2026 Global: Hernia Mesh Devices Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
The hernia mesh devices market is dominated by ten major companies that collectively control substantial market share through technological innovation and strategic positioning. Medtronic plc, headquartered in Dublin, Ireland, leads the market as a multinational medical technology company with extensive global manufacturing and research facilities. Johnson & Johnson Services, Inc. (through its Ethicon subsidiary), based in New Brunswick, New Jersey, USA, ranks among the top players and recently launched its CONTOUR Precision Mesh with Flex-Fit technology. Becton, Dickinson and Company (BD), located in Franklin Lakes, New Jersey, USA, operates as a leading medical technology manufacturer offering over 30 hernia repair products through its C.R. Bard subsidiary. W.L. Gore & Associates, Inc., headquartered in Newark, Delaware, USA, specializes in materials science and produces Gore-Tex mesh products, including the recently launched GORE SYNECOR Intraperitoneal Biomaterial. B. Braun Melsungen AG, based in Melsungen, Germany, maintains significant market presence with FDA-cleared anti-adhesion coated mesh technology.
Cook Medical Inc., situated in Bloomington, Indiana, USA, operates as a global medical technology company that recently introduced the Biodesign Hernia Graft for biologic mesh applications. Atrium Medical Corporation (part of Getinge Group), located in Hudson, New Hampshire, USA, represents another key player with substantial product offerings in the hernia repair market. LifeCell Corporation (acquired by AbbVie/Allergan), headquartered in Branchburg, New Jersey, USA, specializes in regenerative medicine and launched the Strattice Open-Weave Tissue Matrix for biologic mesh applications. Baxter International Inc., based in Deerfield, Illinois, USA, maintains a significant portfolio within the hernia mesh devices sector. Integra LifeSciences Holdings Corporation, headquartered in Princeton, New Jersey, USA, rounds out the ten major players with established market presence in hernia repair solutions.
These ten companies collectively demonstrate the market's moderate fragmentation while maintaining strong competitive positions. The market is characterized by substantial investment in research and development, with leading players focusing on developing synthetic, biologic, and hybrid mesh solutions to improve patient outcomes and reduce post-operative complications. North America represents the dominant geographic market, with these companies maintaining strong manufacturing and sales infrastructure throughout the region. Legal liabilities from post-market complications have required major players to allocate significant financial reserves, exemplified by BD's USD 1 billion settlement and Getinge's SEK 450 million settlement, reflecting the regulatory environment surrounding hernia mesh devices. The competitive landscape continues to evolve through mergers and acquisitions, with companies strengthening technological capabilities and expanding product portfolios to capture growing market demand projected to reach USD 4.42 billion by 2034.
The hernia mesh devices market is dominated by ten major companies that collectively control substantial market share through technological innovation and strategic positioning. Medtronic plc, headquartered in Dublin, Ireland, leads the market as a multinational medical technology company with extensive global manufacturing and research facilities. Johnson & Johnson Services, Inc. (through its Ethicon subsidiary), based in New Brunswick, New Jersey, USA, ranks among the top players and recently launched its CONTOUR Precision Mesh with Flex-Fit technology. Becton, Dickinson and Company (BD), located in Franklin Lakes, New Jersey, USA, operates as a leading medical technology manufacturer offering over 30 hernia repair products through its C.R. Bard subsidiary. W.L. Gore & Associates, Inc., headquartered in Newark, Delaware, USA, specializes in materials science and produces Gore-Tex mesh products, including the recently launched GORE SYNECOR Intraperitoneal Biomaterial. B. Braun Melsungen AG, based in Melsungen, Germany, maintains significant market presence with FDA-cleared anti-adhesion coated mesh technology.
Cook Medical Inc., situated in Bloomington, Indiana, USA, operates as a global medical technology company that recently introduced the Biodesign Hernia Graft for biologic mesh applications. Atrium Medical Corporation (part of Getinge Group), located in Hudson, New Hampshire, USA, represents another key player with substantial product offerings in the hernia repair market. LifeCell Corporation (acquired by AbbVie/Allergan), headquartered in Branchburg, New Jersey, USA, specializes in regenerative medicine and launched the Strattice Open-Weave Tissue Matrix for biologic mesh applications. Baxter International Inc., based in Deerfield, Illinois, USA, maintains a significant portfolio within the hernia mesh devices sector. Integra LifeSciences Holdings Corporation, headquartered in Princeton, New Jersey, USA, rounds out the ten major players with established market presence in hernia repair solutions.
These ten companies collectively demonstrate the market's moderate fragmentation while maintaining strong competitive positions. The market is characterized by substantial investment in research and development, with leading players focusing on developing synthetic, biologic, and hybrid mesh solutions to improve patient outcomes and reduce post-operative complications. North America represents the dominant geographic market, with these companies maintaining strong manufacturing and sales infrastructure throughout the region. Legal liabilities from post-market complications have required major players to allocate significant financial reserves, exemplified by BD's USD 1 billion settlement and Getinge's SEK 450 million settlement, reflecting the regulatory environment surrounding hernia mesh devices. The competitive landscape continues to evolve through mergers and acquisitions, with companies strengthening technological capabilities and expanding product portfolios to capture growing market demand projected to reach USD 4.42 billion by 2034.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
